OPPORTUNITY FOR DISCERNING INVESTORS

A Compelling Investment Thesis Built on Scarcity & Growth

The Golden Mile presents a powerful and time-sensitive investment proposition, uniquely positioned at the intersection of legislative scarcity, robust market fundamentals, and potent growth catalysts. This is not a speculative asset but a strategic acquisition in a supply-constrained market with clear, data-driven drivers for capital appreciation and rental demand. For the sophisticated investor, it offers a rare opportunity to deploy capital into a trophy-grade, income-producing asset with favourable tax treatment and significant upside potential.

The Scarcity Imperative: Legislated Supply Constraint

The most powerful driver of value is scarcity, and The Golden Mile benefits from two key legislative barriers that protect its status as a rare commodity:

1. Strata-Titled Office Ban: Effective 15 March 2022, the URA prohibited the strata subdivision of new commercial developments in Singapore’s Central Area. The Golden Mile is one of the last projects to offer brand-new, strata-titled office units for private ownership in this prime zone. With only 16.6% of Singapore’s office stock being strata-titled, this finite supply of 156 units enters a market with intense demand from SMEs, family offices, and investors.

2. Medical Suite Floor Area Cap: Since 2014, URA/MOH rules cap medical clinic GFA in commercial buildings at 3,000 sqm or 20% of total GFA. The Golden Mile’s 19 medical suites occupy this entire allocated quota, making them a regulated rarity. Driven by an aging population and high demand from practitioners who typically sign long leases, these suites represent a stable, high-demand asset class.